- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01495780
eRT Remote Health Monitoring
Feasibility and Cost Effectiveness of Physiological Monitoring at Home in COPD Patients
Remote Health Monitoring (RHM) is the assessment of one's own symptoms at home between doctor visits, using things like at-home breathing tests, electronic diaries to answer questionnaires, and other monitoring devices. The hypothesis of this study is that the health and quality of life of people with COPD who do RHM for one year will be better than people with COPD who do not do RHM. Subjects who are at least 40 years old, have been diagnosed with chronic obstructive pulmonary disease (COPD), also known as chronic bronchitis or emphysema, and are current or former smokers will be invited to participate. This study is paid for by eResearch Technology (eRT).
Subjects will complete 2 visits at UCLA, separated by one year of RHM. All subjects will participate in RHM. RHM will involve daily monitoring at home using a few electronic devices: blood oxygen levels, symptoms, medication use, breathing tests, and activity monitoring. Visits will include physical exam and medical history, ECG, questionnaires, breathing tests, and exercise tests.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90095
- UCLA David Geffen School of Medicine
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Age >40 years.
- Clinical diagnosis of moderate to severe COPD in accordance with the definition of the American Thoracic Society (ATS).9
- Smoking history >10 pack-years.
- Postbronchodilator FEV1/FVC<70% and FEV1<70% based on NHANES III reference values
- Domestic situation felt to be supportive of remote health monitoring.
- Ability to give informed consent.
Exclusion Criteria:
- Clinical diagnosis of asthma.
- Pulmonary disease other than COPD (e.g., lung cancer, sarcoidosis, active tuberculosis, bronchiectasis, pulmonary fibrosis, cystic fibrosis, or alpha-1-antitrypsin deficiency) or had lung volume reduction.
- Any other active disease that, in the opinion of the investigator, would put the safety of the subject at risk through study participation (e.g. unstable cardiovascular disease, renal failure, stroke).
- Previously diagnosed cancer is considered a significant disease unless it is in complete remission for 2 years at the initial visit.
- Any other disease that is life-threatening and carries a prognosis less than two years that, in the opinion of the investigator, is likely to influence the clinical course during the conduct of this trial.
- Myocardial infarction within 6 weeks of enrolment.
- Use of long-term oxygen therapy (LTOT) prescribed for greater than 12 hours a day.
- A known or suspected history of drug or alcohol abuse within 2 years prior to the initial visit.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Remote Health Monitoring
Subjects assigned to this arm will conduct daily at-home health monitoring using several electronic devices that will transmit data back to the study team.
Everyday, subjects will measure pulse oximetry (SpO2) using a finger clip, answer questions about symptoms and medication use, answer a quality of life questionnaire, perform breathing tests, and record physical activity (using a physical activity monitor that will be mailed to the study team).
Wearing the activity monitor is optional and will only occur during months 1, 6, and 12.
|
1 year of remote health monitoring of symptoms, medication use, breathing tests, physical activity, and healthcare utilization.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Compliance with daily RHM
Tidsramme: 1 year
|
Compliance with daily RHM as a percentage of study days
|
1 year
|
|
Integrity of spirometric data
Tidsramme: 1 year
|
Integrity of the spirometric data in terms of the standard American Thoracic Society and European Respiratory Society criteria for acceptability and repeatability.
|
1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Antal lægebesøg
Tidsramme: 1 år
|
1 år
|
|
|
Rate of adoption of RHM
Tidsramme: 1 year
|
Time it takes for subjects to become compliant with daily RHM
|
1 year
|
|
Treatment adherence
Tidsramme: 1 year
|
Treatment adherence in terms of percentage of days prescribed treatment* is taken (* treatment separate from study, prescribed by personal physician)
|
1 year
|
|
Time to first COPD exacerbation
Tidsramme: 1 year
|
Time to first COPD exacerbation as defined by standard criteria.
|
1 year
|
|
Number of COPD exacerbations per year
Tidsramme: 1 year
|
1 year
|
|
|
Proportion of subjects experiencing one or more exacerbations
Tidsramme: 1 year
|
1 year
|
|
|
Mean daily FEV1
Tidsramme: 1 year
|
1 year
|
|
|
Mean daily IC
Tidsramme: 1 year
|
1 year
|
|
|
Mean daily activity level
Tidsramme: 1 year
|
1 year
|
|
|
Mean daily SpO2
Tidsramme: 1 year
|
1 year
|
|
|
Daily symptom scores
Tidsramme: 1 year
|
1 year
|
|
|
Number of emergency department visits
Tidsramme: 1 year
|
1 year
|
|
|
Number of hospitalizations
Tidsramme: 1 year
|
1 year
|
|
|
Number of days spent in hospital
Tidsramme: 1 year
|
1 year
|
|
|
Health care costs
Tidsramme: 1 year
|
Inferred health care costs using a standard cost framework model
|
1 year
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- eRT RHM
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Remote Health Monitoring
-
LifeBridge HealthAmerican Heart Association (AHA)AfsluttetKoronararteriesygdom | Hjertefejl | Diabetes mellitusForenede Stater
-
CAMC Health SystemWVCTSIAfsluttet
-
Arizona State UniversityUniversity of Oregon; National Heart, Lung, and Blood Institute (NHLBI); Northwestern... og andre samarbejdspartnereRekrutteringKlinisk forsøgForenede Stater
-
Kubota Vision Inc.AfsluttetAldersrelateret makuladegenerationForenede Stater
-
Pennington Biomedical Research CenterLouisiana State University Health Care Services DivisionAfsluttetForhøjet blodtryk | Fedme | Diabetes | OvervægtigForenede Stater
-
Biotronik Japan, Inc.Afsluttet
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Rekruttering
-
Bluedrop Medical LimitedAfsluttetDiabetisk fodForenede Stater
-
Medical University of ViennaAfsluttetIkke-traumatisk kompartmentsyndrom i benØstrig